Literature DB >> 33586046

What is a reasonable framework for new non-validated treatments?

Gert Helgesson1.   

Abstract

Entities:  

Year:  2021        PMID： 33586046      PMCID： PMC7935739          DOI： 10.1007/s11017-020-09537-6

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN： 1386-7415


× No keyword cloud information.
  14 in total

Review 1.  A decade of reversal: an analysis of 146 contradicted medical practices.

Authors:  Vinay Prasad; Andrae Vandross; Caitlin Toomey; Michael Cheung; Jason Rho; Steven Quinn; Satish Jacob Chacko; Durga Borkar; Victor Gall; Senthil Selvaraj; Nancy Ho; Adam Cifu
Journal:  Mayo Clin Proc       Date:  2013-07-18       Impact factor: 7.616

2.  Innovative surgery: the ethical challenges.

Authors:  Jane Johnson; Wendy Rogers
Journal:  J Med Ethics       Date:  2011-06-22       Impact factor: 2.903

3.  Innovation in a Learning Healthcare System.

Authors:  Henry S Sacks; Rosamond Rhodes
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229

4.  Regulating Clinical Innovation: Trachea Transplants and Tissue Engineering.

Authors:  Gardar Arnason
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229

5.  Profit Motives Require a Proscriptive Approach.

Authors:  Casey Jo Humbyrd; Matthew Wynia
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229

6.  The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.

Authors:  Timothy Daly; Ignacio Mastroleo; David Gorski; Stéphane Epelbaum
Journal:  Theor Med Bioeth       Date:  2021-01-18

7.  Macchiarini scandal is a valuable lesson for the Karolinska Institute.

Authors: 
Journal:  Nature       Date:  2016-09-08       Impact factor: 49.962

8.  Professional and public double standards on clinical experimentation.

Authors:  I Chalmers; W A Silverman
Journal:  Control Clin Trials       Date:  1987-12

9.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

10.  Reversal of cognitive decline: a novel therapeutic program.

Authors:  Dale E Bredesen
Journal:  Aging (Albany NY)       Date:  2014-09       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.